ACR Highlights… ACR Convergence 2025 Highlights- Vasculitis 24 Nov 2025 MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial Abstract format and assignment number: Oral presentation 0891 Presenting author: M Samson (France) Date: Monday…
ACR Highlights… ACR Convergence 2025 Highlights- Paediatric rheumatology 24 Nov 2025 Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis <2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry Abstract format and assignment…
ACR Highlights… ACR Convergence 2025 Highlights- Rheumatoid Arthritis 24 Nov 2025 A Phase 1 Study of Autologous CAR-Treg Cells in Refractory Rheumatoid Arthritis: Interim Report of Safety and Efficacy Abstract format and assignment number: Late-breaking abstract LB23 Presenting author: Kohler Minna…
ACR Highlights… ACR Convergence 2025 Highlights- Basic and Translational Research 24 Nov 2025 Longitudinal peripheral blood multi-omic profiling in at-risk individuals uncovers immune signatures and predictive models for future rheumatoid arthritis conversion Abstract format and assignment number: Oral presentation 0774 Presenting author: J.…
ACR Highlights… ACR Convergence 2025 Highlights- Connective Tissue Diseases 24 Nov 2025 Redefining When to Biopsy the Kidney in Patients with SLE Abstract format and assignment number: Oral presentation 0772 Presenting author: M Petri (USA) Date: Sunday 26th October 2025 Lupus nephritis is…
ACR Highlights… ACR Convergence 2025 Highlights- Non inflammatory Rheumatic Diseases (Osteoarthritis, Osteoporosis and Metabolic bone disease, etc.) 24 Nov 2025 Romosozumab as a Safe Bone-Forming Treatment for Elderly Patients with Established Cardiovascular Risk Factors Poster presentation: POS 0341 Date: Sunday, 26th October 2025 Presenting author: D. Ramos Castro (Spain) This…
ACR Highlights… ACR Convergence 2025 Highlights- Other inflammatory arthritides (such as CPPD and gout) and autoinflammatory diseases 24 Nov 2025 Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI) Abstract format and assignment number: Oral presentation 0777 Date: Sunday, 26th October 2025 Presenting author: M. Koster…
EMEUNET… Stats Made Simple: Bias and Confounding in research 24 Nov 2025 Bias In research, bias is defined as a systematic deviation of the estimated effect from the truth. Bias threatens internal validity, because the observed association between exposure and outcome does…
EMEUNET… EMEUNET Podcast- Coming soon 24 Nov 2025 Peer Review Programme A new episode of the EMEUNET Podcast is about to be released, focusing on the launch of the new season of the Peer Review Programme, which for…
EMEUNET… Country Liaison Spotlight 24 Nov 2025 Highlights from the EMEUNET Session at the Bulgarian National Conference of Rheumatology 2025 The EMEUNET Country Liaison for Bulgaria Daliya Pencheva had the pleasure of presenting EMEUNET’s mission, activities, and…